160 related articles for article (PubMed ID: 27712975)
1. Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Cebrián A; Gómez Del Pulgar T; Fernández-Aceñero MJ; Borrero-Palacios A; Del Puerto-Nevado L; Martínez-Useros J; Marín-Arango JP; Caramés C; Vega-Bravo R; Rodríguez-Remírez M; Manzarbeitia F; García-Foncillas J
Pathol Res Pract; 2016 Dec; 212(12):1133-1137. PubMed ID: 27712975
[TBL] [Abstract][Full Text] [Related]
2. Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer.
Tut TG; Lim SH; Dissanayake IU; Descallar J; Chua W; Ng W; de Souza P; Shin JS; Lee CS
PLoS One; 2015; 10(6):e0129313. PubMed ID: 26047016
[TBL] [Abstract][Full Text] [Related]
3. PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Li CF
Histopathology; 2015 Jun; 66(7):991-1002. PubMed ID: 25393083
[TBL] [Abstract][Full Text] [Related]
4. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma.
Fernández-Aceñero MJ; Cortés D; Gómez del Pulgar T; Cebrián A; Estrada L; Martínez-Useros J; Celdrán A; García-Foncillas J; Pastor C
Pathol Oncol Res; 2016 Apr; 22(2):377-83. PubMed ID: 26577686
[TBL] [Abstract][Full Text] [Related]
5. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase 1 as predictive marker and therapeutic target for radiotherapy in rectal cancer.
Rödel F; Keppner S; Capalbo G; Bashary R; Kaufmann M; Rödel C; Strebhardt K; Spänkuch B
Am J Pathol; 2010 Aug; 177(2):918-29. PubMed ID: 20581060
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
8. [Polo like kinase 1 expression and prognostic value in gastric carcinomas].
Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):70-2. PubMed ID: 17253180
[TBL] [Abstract][Full Text] [Related]
9. Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients.
Zhang RX; Zhou ZG; Lu SX; Lu ZH; Wan DS; Pan ZZ; Wu XJ; Chen G
Sci Rep; 2017 Nov; 7(1):16043. PubMed ID: 29167471
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH
J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters.
Singh L; Pushker N; Sen S; Singh MK; Chauhan FA; Kashyap S
Clin Exp Ophthalmol; 2015 Aug; 43(6):550-7. PubMed ID: 25754767
[TBL] [Abstract][Full Text] [Related]
12. Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy.
Shim BY; Sun S; Won HS; Lee MA; Hong SU; Jung JH; Cho HM; Ko YH
BMC Cancer; 2016 Mar; 16():207. PubMed ID: 26965179
[TBL] [Abstract][Full Text] [Related]
13. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
14. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.
Sprenger T; Conradi LC; Beissbarth T; Ermert H; Homayounfar K; Middel P; Rüschoff J; Wolff HA; Schüler P; Ghadimi BM; Rödel C; Becker H; Rödel F; Liersch T
Cancer; 2013 Jan; 119(1):26-35. PubMed ID: 22736392
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase 1 expression is a prognostic factor in human colon cancer.
Weichert W; Kristiansen G; Schmidt M; Gekeler V; Noske A; Niesporek S; Dietel M; Denkert C
World J Gastroenterol; 2005 Sep; 11(36):5644-50. PubMed ID: 16237758
[TBL] [Abstract][Full Text] [Related]
16. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
Lin CY; Hsieh PL; Chou CL; Yang CC; Lee SW; Tian YF; Shiue YL; Li WS
Oncology; 2020; 98(8):549-557. PubMed ID: 32408308
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy.
Lee YE; He HL; Shiue YL; Lee SW; Lin LC; Wu TF; Chang IW; Lee HH; Li CF
Tumour Biol; 2015 Sep; 36(10):7675-83. PubMed ID: 25929810
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of polo-like kinase 1 in human gastric cancer.
Weichert W; Ullrich A; Schmidt M; Gekeler V; Noske A; Niesporek S; Buckendahl AC; Dietel M; Denkert C
Cancer Sci; 2006 Apr; 97(4):271-6. PubMed ID: 16630118
[TBL] [Abstract][Full Text] [Related]
19. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of DSG3 in rectal adenocarcinoma treated with preoperative chemoradiotherapy.
Chao TB; Li CF; Lin CY; Tian YF; Chang IW; Sheu MJ; Lee YE; Chan TC; He HL
Future Oncol; 2016 Jun; 12(12):1457-67. PubMed ID: 27040321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]